Takeda CEO Calls For A Paradigm Shift In Japanese R&D; BIO Japan Conference Takeaway Message, Head West...To China
This article was originally published in PharmAsia News
Executive Summary
YOKOHAMA, Japan - Takeda Pharmaceutical Co. CEO Yasuchika Hasegawa encouraged his fellow Japanese companies to embrace a paradigm shift in their approach to R&D, which includes being open to reverse innovation and rethinking how global R&D can be localized
You may also be interested in...
Takeda Shareholders Approve Weber As COO, Setting Up Leadership Handover
Christophe Weber wins shareholder approval as chief operating officer at Takeda as expected, setting up a leadership change at Japan’s top, and oldest, drug company over the opposition of some family members.
Takeda Shareholders Approve Weber As COO Setting Up Leadership Handover
Christophe Weber wins shareholder approval as chief operating officer at Takeda as expected, setting up a leadership change at Japan’s top, and oldest, drug company over the opposition of some family members.
Rearguard Battle At Takeda Unlikely To Derail Globalization Plans
The planned appointment of Christophe Weber as chief operating officer at Asia’s leading pharmaceutical company has ruffled feathers among traditionalists fearful of change.